NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease. MRI magnetic resonance imaging , ultrasound , and clinical breast exams are also used to detect breast cancer, but not as routine screening tools. Ongoing studies are looking at ways to enhance current breast cancer screening options. Technological advances in imaging are creating new opportunities for improvements in both screening and early detection.
Breast cancer prevention: How to reduce your risk - Mayo Clinic
As a result of the significant disruption that is being caused by the COVID pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time. Over the past decade, Breast Cancer Research BCR has also become the highest ranked breast cancer focused title in the field. Edited by one of our Deputy Editors, Dr. Find the collection here. Olopade and Dezheng Huo.
Irish scientists found that a specific molecule could selectively kill the cells of triple negative breast cancer while sparing normal cells. Photograph: iStock. Irish scientists have discovered a molecule that can selectively kill cells of a hard-to-treat type of breast cancer, which could lead to a new therapy with better outcomes for patients.
Our Scientific Advisory Board provides strategic guidance and direction for our grantmaking programs. The Komen Scholars are an international advisory group of 60 distinguished leaders in breast cancer research and advocacy. They lend their expertise to our peer review process to help us select the best science and make the greatest impact on breast cancer. The Advocates in Science Steering Committee is comprised of seven experienced advocates who work closely with Komen staff to develop training for other research and patient advocates and actively engage our advisory boards in the benefits and outcomes of effective research advocacy. Susan G.